Aditxt, Inc. (ADTX)
0.5071
-0.05
(-9.24%)
USD |
NASDAQ |
Feb 20, 16:00
0.5339
+0.03
(+5.28%)
After-Hours: 20:00
Aditxt EPS Diluted (Quarterly) : -548.81 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | -0.0412 |
| BioStem Technologies, Inc. | 0.0328 |
| Iovance Biotherapeutics, Inc. | -0.2507 |
| Protokinetix, Inc. | -0.0002 |
| GB Sciences, Inc. | -0.0002 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -24.21M |
| Revenue (Quarterly) | 0.0007M |
| Total Expenses (Quarterly) | 24.05M |
| Enterprise Value | 8.650M |
| Gross Profit Margin (Quarterly) | -9.64K% |
| Profit Margin (Quarterly) | -3.46M% |
| Earnings Yield | -1.08M% |
| Normalized Earnings Yield | -1.069M |